|
2024
|
Invention
|
Biodegradable implant for sustained trans-nasal delivery of therapeutic agents to the brain.
A m... |
|
|
Invention
|
Fiber optic detection system for delivery of photobiomodulation therapy. A system for cochlear ph... |
|
|
Invention
|
Biopolymer-based tympanostomy tubes with programmable, tunable, and on-demand degradation. Disclo... |
|
|
Invention
|
Base editing approaches to treat abca4-associated stargardt disease. Described herein are base ed... |
|
|
Invention
|
Altering tissue tropism of adeno-associated viruses.
This disclosure provides compositions and m... |
|
|
Invention
|
Methods of delivering an agent to the eye.
Methods of delivering agents to structures within the... |
|
|
Invention
|
Treatment of hearing loss. Compositions for regeneration of inner cells and for treating hearing ... |
|
|
Invention
|
Methods and polymer compositions for treating retinal detachment and other ocular disorders.
The... |
|
|
Invention
|
Viral vector functionalized core-shell scaffold. Scaffolds, including Nerve Guidance Scaffolds (N... |
|
2023
|
Invention
|
Intra-ocular optical coherence tomography apparatus and method for vitreoretinal surgery. An opti... |
|
|
Invention
|
Inhibition of lysine demethylase 1 (lsd1) induces differentiation of hair cells.
Methods for the... |
|
|
Invention
|
System and method for the treatment of amblyopia.
A system and methods for the treatment of ambl... |
|
|
Invention
|
Compositions and methods using reelin in alzheimer's disease. Described herein are methods and co... |
|
|
Invention
|
Mobile device application for ocular misalignment measurement.
Disclosed are a mobile device and... |
|
|
Invention
|
Treatment of rhinosinusitis with p-glycoprotein inhibitors.
Provided herein are, inter alia, met... |
|
|
Invention
|
Runx1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with ... |
|
|
Invention
|
Compositions and methods for hearing loss. Methods and compositions for use in treating subjects ... |
|
|
Invention
|
Methods of predicting ancestral virus sequences and uses thereof. Methods are described for predi... |
|
|
Invention
|
Lipid nanoparticles for delivery to the eye or ear. Disclosed herein are methods and compositions... |
|
|
Invention
|
Exon skipping to treat usher syndrome. USH2AUSH2AUSH2AUSH2A gene or transcripts, and methods of u... |
|
|
Invention
|
A fully differential piezoelectric microphone and amplifier system for cochlear implants and othe... |
|
|
Invention
|
An ultra-flexible miniature optical coherence tomography catheter and imaging method for endomicr... |
|
2022
|
Invention
|
Methods and compositions for preventing and treating retinal damage in glaucoma.
The invention p... |
|
|
Invention
|
Novel methods of using adeno-associated virus 11 (aav11).
The present application relates to com... |
|
|
Invention
|
Novel methods of using adeno-associated virus 11 (aav11). The present application relates to comp... |
|
|
Invention
|
Secreted p-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis.
Methods for ident... |
|
|
Invention
|
High efficiency purification of divergent aav serotypes using aavx affinity chromatography. Discl... |
|
|
Invention
|
High efficiency purification of divergent aav serotypes using aavx affinity chromatography.
Disc... |
|
|
Invention
|
Submucosal implantable drug delivery apparatuses, systems, and methods.
The present disclosure r... |
|
|
Invention
|
Methods and compositions for regenerating hair cells in the inner ear of adult mammals.
Provided... |
|
|
Invention
|
Optimized aav-based vaccine. The present application relates to compositions and methods for elic... |
|
|
Invention
|
Methods and compositions for modulating the interaction between adeno-associated virus (aav) and ... |
|
2021
|
Invention
|
System for diagnosis of an otitis media via a portable device.
Systems and methods are provided ... |
|
|
Invention
|
Compositions and methods for mucosal drug delivery.
Disclosed herein are polymers, nanoparticles... |
|
|
Invention
|
Methods and compositions for restricting biodistribution of aav.
The present disclosure relates ... |
|
|
Invention
|
Drug combination kits and methods of drug delivery.
A kit for delivering a drug formulation to t... |
|
|
Invention
|
Combination verapamil and mometasone therapy for the treatment of chronic rhinosinusitis.
Descri... |
|
|
Invention
|
Targeted base editing of the ush2a gene.
The disclosure provides methods of deaminating adenosin... |
|
|
Invention
|
Highly-networked coronavirus immunogen composition.
A method of preventing or treating COVID inf... |
|
|
Invention
|
Systems and methods for controlling the spread of airborne materials during clinical or laborato... |
|
|
Invention
|
Methods of making and using a vaccine against coronavirus.
Provided herein are vaccines against ... |
|
2020
|
Invention
|
Melt-extrudable 3d printing inks.
Described herein are melt-extrudable biodegradable inks for 3D... |
|
|
Invention
|
Ocular sealants and methods of using the same.
The present disclosure presents sealant compositi... |
|
|
Invention
|
Predicting clinical parameters relating to glaucoma from central visual field patterns.
Systems ... |
|
|
Invention
|
Isolation, enrichment and expansion of cone progenitor cells and uses thereof.
Progenitor cells ... |
|
2019
|
Invention
|
Inhibition of cystatins for the treatment of chronic rhinosinusitis.
Methods and compositions fo... |
|
|
Invention
|
Altering tissue tropism of adeno-associated viruses. This disclosure provides compositions and me... |
|
2018
|
P/S
|
Hospital services; Medical services |
|
2011
|
P/S
|
keratoprostheses |
|
2010
|
P/S
|
hospital services; medical services |
|
2009
|
P/S
|
hospital services |
